27.70
-0.39 (-1.39%)
| Previous Close | 28.09 |
| Open | 28.23 |
| Volume | 110,844 |
| Avg. Volume (3M) | 297,500 |
| Market Cap | 958,246,080 |
| Price / Earnings (TTM) | 36.93 |
| Price / Earnings (Forward) | 22.17 |
| Price / Sales | 1.22 |
| Price / Book | 3.15 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2025 |
| Profit Margin | 3.40% |
| Operating Margin (TTM) | 6.03% |
| Diluted EPS (TTM) | 0.760 |
| Quarterly Revenue Growth (YOY) | 33.70% |
| Quarterly Earnings Growth (YOY) | 58.50% |
| Total Debt/Equity (MRQ) | 105.10% |
| Current Ratio (MRQ) | 1.41 |
| Operating Cash Flow (TTM) | 17.52 M |
| Levered Free Cash Flow (TTM) | 4.89 M |
| Return on Assets (TTM) | 4.00% |
| Return on Equity (TTM) | 11.41% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | The Pennant Group, Inc. | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 1.00 |
|
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 3.98% |
| % Held by Institutions | 91.33% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 40.00 (Stephens & Co., 44.40%) | Buy |
| Median | 34.00 (22.74%) | |
| Low | 30.00 (Jefferies, 8.30%) | Buy |
| Average | 34.80 (25.63%) | |
| Total | 5 Buy | |
| Avg. Price @ Call | 26.21 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Truist Securities | 02 Dec 2025 | 34.00 (22.74%) | Buy | 29.27 |
| Wells Fargo | 18 Nov 2025 | 31.00 (11.91%) | Buy | 26.09 |
| RBC Capital | 17 Nov 2025 | 39.00 (40.79%) | Buy | 25.40 |
| Jefferies | 24 Oct 2025 | 30.00 (8.30%) | Buy | 25.24 |
| Stephens & Co. | 09 Oct 2025 | 40.00 (44.40%) | Buy | 25.04 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 06 Nov 2025 | Announcement | Pennant Group to Participate in the 2025 Stephens Annual Investment Conference |
| 05 Nov 2025 | Announcement | The Pennant Group Announces Expansion of Credit Facility |
| 05 Nov 2025 | Announcement | Pennant Reports Third Quarter 2025 Results |
| 04 Nov 2025 | Announcement | Pennant Acquires Senior Living Communities in Idaho and Wisconsin |
| 24 Oct 2025 | Announcement | Pennant Announces Third Quarter 2025 Earnings Release and Call |
| 02 Oct 2025 | Announcement | Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys |
| 02 Oct 2025 | Announcement | UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys |
| 11 Sep 2025 | Announcement | Pennant Group to Participate in the 2025 Jefferies Healthcare Services Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |